Skip to Main Content

Paper Details

Pathway-specific engineered mouse allograft models functionally recapitulate human serous epithelial ovarian cancer.
PLoS One
14
2014
Brca1, Brca1-deficient tumors, Brca1-wild type, Brca1-wild type and Brca1-deficient tumors, Brca1-wild type tumors, Brca2, GEM models, Ovarian tumors deficient in Brca1, PARP, Rb, SEOC, Tp53, cancer, cisplatin, engineered mouse allograft models, human, mouse, olaparib, ovarian cancer, ovarian cancers, patients, platinum, serous epithelial ovarian cancer, tumors
Author NameAffiliation
Robert M StephensInc., Frederick National Laboratory for Cancer Research
Robert M StephensInc., Frederick National Laboratory for Cancer Research
  • 1 - 2

Datasets

Release 1.2